MAP2K4 and hepatocellular carcinoma: Furthermore, circRNA MAP2K4 (circMAP2K4) was validated to promote HCC cell proliferation by binding with miRNA 139-5p (miR-139-5p) to promote YTHDF1 expression, providing clues for HCC therapeutic targets (Chi et al., 2021).